Kent Imaging and Marathon Medical expand wound imaging access in VA facilities

Kent Imaging has partnered with Marathon Medical to broaden access to its SnapshotNIR and SnapshotGLO wound imaging devices across U.S. Department of Veterans Affairs healthcare facilities. The deal aims to help clinicians spot wound complications earlier and support better outcomes for Veterans, especially patients with diabetes and peripheral arterial disease.

Why it matters: - Chronic wounds and lower-extremity complications remain a major health issue for Veterans. - Earlier bedside information on tissue oxygenation and bacterial burden can help clinicians act sooner. - The partnership is aimed at reducing preventable amputations and improving healing outcomes in VA care.

What happened: - Kent Imaging announced a partnership with Marathon Medical to expand access to Kent’s wound imaging technologies across U.S. Department of Veterans Affairs healthcare facilities. - The agreement covers SnapshotNIR, SnapshotGLO and future Kent Imaging product developments. - Marathon Medical is a Service-Disabled Veteran-Owned Small Business focused on federal healthcare distribution. - Marathon Medical has more than 20 years of experience serving the VA, the Department of Defense and other federal healthcare agencies.

The details: - Kent Imaging’s devices provide point-of-care tissue assessment. - SnapshotNIR measures tissue oxygenation with near-infrared imaging. - SnapshotGLO uses bacterial autofluorescence imaging to show wound bioburden presence and distribution in real time. - Kent Imaging said the devices help clinicians identify patients at risk for wound complications earlier and support better outcomes for America’s Veterans. - Marathon Medical was founded by Vietnam Veteran John St. Leger. - Marathon Medical is headquartered in Aurora, Colorado. - The company works with VA hospitals, military treatment facilities and other government agencies to help providers access medical technologies. - Kent Imaging is based in Calgary, Alberta, Canada. - Kent Imaging designs, manufactures and markets medical devices for wound care, vascular and surgical specialties. - SnapshotNIR was initially cleared by the FDA and Health Canada in 2017 and received CE marking in 2025. - SnapshotGLO received FDA 510(k) clearance in 2025. - Kent Imaging included a LinkedIn page in the release.

Between the lines: - The deal pairs a wound-imaging maker with a veteran-owned federal distributor that already has deep VA relationships. - That setup should make it easier for Kent Imaging to reach a government healthcare market that can be slow to adopt new devices. - The partnership also fits both companies’ messaging around serving Veterans through medical innovation.

What's next: - Kent Imaging and Marathon Medical will push the Snapshot suite into more VA healthcare settings. - The companies are positioning the partnership as a way to expand access to advanced wound imaging across the federal healthcare system. - Kent Imaging said the collaboration supports future product rollouts as well.

The bottom line: - Kent Imaging is betting that Marathon Medical’s federal sales experience can speed adoption of its wound imaging tools inside VA care.**